• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G125
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Pacing Problem (1439)
Patient Problems Syncope/Fainting (4411); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/04/2023
Event Type  Injury  
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that this recently implanted cardiac resynchronization therapy defibrillator (crt-d) system exhibited noise with oversensing and pacing inhibition.Technical services (ts) reviewed troubleshooting options and possible causes.This crt-d remains in service.No adverse patient effects were reported.
 
Event Description
It was reported that this this recently implanted cardiac resynchronization therapy defibrillator (crt-d) system exhibited noise with oversensing and pacing inhibition.Technical services (ts) reviewed troubleshooting options and possible causes.This crt-d remains in service.No adverse patient effects were reported.Additional information received reported that the patient implanted with this cardiac resynchronization therapy defibrillator (crt-d) system was admitted to the hospital and underwent further evaluation due to experiencing syncopal episodes.As a result, the physician was considering possible revision.The previously reported oversensing was not reproducible with isometrics, however no pacing inhibition was observed once biventricular pacing was programmed on.Additionally, all lead measurements were within normal range.The patient was kept under observation for an additional night before getting discharged from the hospital.This crt-d system remains in service and will continue to be monitored at this time.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18161852
MDR Text Key328436836
Report Number2124215-2023-65051
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/12/2024
Device Model NumberG125
Device Catalogue NumberG125
Device Lot Number152716
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age82 YR
Patient SexMale
-
-